Lipoprotein signal peptidase-deficient Streptococcus pneumoniae exhibits impaired Toll-like receptor 2-stimulatory

Hisanori Domon1,2, Satoru Hirayama1, Toshihito Isono1

  • 1Division of Microbiology and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

PubMed

Insights

This study shows that a Streptococcus pneumoniae strain lacking lipoprotein signal peptidase (LspA) has reduced lipoproteins. This impairment leads to a weaker innate immune response, decreasing inflammation and cytokine production.

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Streptococcus pneumoniae causes community-acquired pneumonia.
  • Innate immune cells detect pneumococcal lipoproteins via Toll-like receptor 2, triggering inflammation.

Purpose of the Study:

  • To investigate the host immune response to a Streptococcus pneumoniae strain deficient in lipoprotein signal peptidase (LspA).
  • To understand the role of LspA in lipoprotein maturation and its impact on bacterial virulence.

Main Methods:

  • Generated a LspA-deficient S. pneumoniae strain.
  • Utilized Triton X-114 phase separation to assess lipoprotein expression.
  • Measured nuclear factor-κB activation and cytokine production in THP-1 cells.

Main Results:

  • The LspA-deficient strain exhibited significantly lower lipoprotein expression compared to the wild-type strain.
  • THP-1 cells stimulated with the LspA-deficient strain showed reduced nuclear factor-κB activation.
  • Cytokine production was decreased in response to the LspA-deficient S. pneumoniae strain.

Conclusions:

  • LspA is crucial for lipoprotein maturation in Streptococcus pneumoniae.
  • Impaired lipoprotein expression in LspA-deficient strains leads to a diminished innate immune response.
  • Targeting LspA could be a potential strategy to attenuate pneumococcal virulence.